Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Understanding when most people start planning for retirement can help you avoid delays. Find out the trends and best practices for timely planning.
22,030 articlesBiotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
SLV rose again this week as bearish chatter on social boards quieted and options hedging nudged the silver-focused ET...
Merck stock jumps on a major restructuring, but Reddit sentiment shows growing skepticism as investors weigh Keytruda...
In a high-stakes bidding war, Netflix may have positioned itself to win by losing the bid for Warner Bros Discovery. ...
As kontoor brands (ktb) 2025 unfolds, investors are weighing margins, brand strength, and growth channels. This artic...
Tariff refund delays could threaten cash flow for thousands of importers, with a Cato Institute estimate placing the ...
A wave of new analyst ratings hits screens Friday, touching auto parts, semiconductors, software and biotech. Upgrade...
A new market dynamic shows Bitcoin ETF assets can shrink without investors selling, as mark-to-market losses mute the...
As mega-cap tech pours capital into AI, investors seek signs of durable returns. This piece analyzes which firms stan...
I dove into Plug Power in a hopeful stretch for green energy gains, only to see a dramatic crash. This is the hard-wo...
When a fintech stock investor trims a large stake in a rising Brazilian payments firm, traders and everyday investors...
Nvidia is facing a mixed start to 2026, but the long-term case remains intact. This article explains why a 40% jump b...